INTRODUCTION: Depression therapy has been linked to negative effects on energy metabolism, which can be attributed to various factors, including an ongoing inflammatory process commonly seen in metabolic disorders. Unhealthy lifestyle choices of patients and the impact of antidepressants on body weight and lipid and glucose metabolism also contribute to these metabolic side effects. Although not as pronounced as other psychopharmaceuticals, the increasing use of antidepressants raises concerns about their potential impact on public health. The study aimed to evaluate the short- and long-term effects of the antidepressant citalopram and its long-term combination with a special diet on metabolic parameters in mice. METHODS: Animals were randomly divided into 5 groups - control, control + special diet, citalopram (10 mg/kg for 35 days), citalopram + special diet (10 mg/kg for 35 days), and citalopram (10 mg/kg for 7 days). After a described time of administration, animals were anesthetized, blood and fat and liver tissues were collected. Biochemical parameters of lipid metabolism (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides) and glucose were analyzed using spectrophotometry and relevant adipokines and cytokines were evaluated by ELISA. RESULTS: After a week of application of citalopram, we observed dyslipidemia that persisted even at the end of the 5-week experiment. Furthermore, after 5 weeks of citalopram administration, we observed a significant decrease in body weight gain and decreased leptin levels. Changes in lipid metabolism, higher levels of adipokines leptin and PAI-1 were observed due to the special diet after 5 weeks. CONCLUSIONS: Our research suggests that the effects of citalopram and a diet on the metabolism of mice can be significant, both in the short term (1 week) and in the long term (5 weeks).

BioVendor Laboratorní Medicína a s Research and Diagnostic Products Division Brno Czechia

Department of Human Pharmacology and Toxicology Faculty of Pharmacy University of Veterinary and Pharmaceutical Sciences in Brno Brno Czechia

Department of Pharmacology and Toxicology Faculty of Pharmacy Masaryk University Brno Czechia

Zobrazit více v PubMed

Capuron L, Lasselin J, Castanon N. Role of adiposity-driven inflammation in depressive morbidity. Neuropsychopharmacology. 2017;42(1):115–28. PubMed PMC

Kotolová H, Hammer T. Inflammation as a part of the pathophysiology of depression and the possibility of its influence by polyunsaturated fatty acids. Psychiatr Pro Praxi. 2019;20(2):60–3.

De Hert M, Dekker JM, Wood D, Kahl KG, Holt RIG, Möller HJ. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry. 2009;24(6):412–24. PubMed

Mulugeta A, Zhou A, King C, Hyppönen E. Association between major depressive disorder and multiple disease outcomes: a phenome-wide Mendelian randomisation study in the UK Biobank. Mol Psychiatry. 2020;25(7):1469–76. PubMed

Arterburn D, Sofer T, Boudreau DM, Bogart A, Westbrook EO, Theis MK, et al. . Long-term weight change after initiating second-generation antidepressants. J Clin Med. 2016;5(4):48. PubMed PMC

Gafoor R, Booth HP, Gulliford MC. Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study. BMJ. 2018;361:k1951. PubMed PMC

Kucerova J, Babinska Z, Horska K, Kotolova H. The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review. Biomed Pap. 2015;159(2):208–14. PubMed

Shi Z, Atlantis E, Taylor AW, Gill TK, Price K, Appleton S, et al. . SSRI antidepressant use potentiates weight gain in the context of unhealthy lifestyles: results from a 4-year Australian follow-up study. BMJ Open. 2017;7(8):e016224. PubMed PMC

Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Semercioz A. Serum leptin levels in patients with premature ejaculation before and after citalopram treatment. BJU Int. 2003;91(3):252–4. PubMed

Carvalho AF, Rocha DQC, McIntyre RS, Mesquita LM, Köhler CA, Hyphantis TN, et al. . Adipokines as emerging depression biomarkers: a systematic review and meta-analysis. J Psychiatr Res. 2014;59:28–37. PubMed

Horská K, Kučerová J, Suchý P, Kotolová H. Metabolic syndrome: dysregulation of adipose tissue endocrine function. Ceska Slov Farm. 2014;63(4):152–9. PubMed

Lawson EA, Miller KK, Blum JI, Meenaghan E, Misra M, Eddy KT, et al. . Leptin levels are associated with decreased depressive symptoms in women across the weight spectrum, independent of body fat. Clin Endocrinol. 2012;76(4):520–5. PubMed PMC

Alonso-Pedrero L, Bes-Rastrollo M, Marti A. Effects of antidepressant and antipsychotic use on weight gain: a systematic review. Obes Rev. 2019;20(12):1680–90. PubMed

Gui Y, Cai Z, Silha JV, Murphy LJ. Variations in parametrial white adipose tissue mass during the mouse estrous cycle: relationship with the expression of peroxisome proliferator-activated receptor-gamma and retinoic acid receptor-alpha. Can J Physiol Pharmacol. 2006;84(8–9):887–92. PubMed

Giles ED, Jackman MR, Johnson GC, Schedin PJ, Houser JL, MacLean PS. Effect of the estrous cycle and surgical ovariectomy on energy balance, fuel utilization, and physical activity in lean and obese female rats. Am J Physiol Regul Integr Comp Physiol. 2010;299(6):R1634–42. PubMed PMC

Saavedra-Peña RDM, Taylor N, Flannery C, Rodeheffer MS. Estradiol cycling drives female obesogenic adipocyte hyperplasia. Cell Rep. 2023;42(4):112390. PubMed PMC

Della Torre S, Mitro N, Fontana R, Gomaraschi M, Favari E, Recordati C, et al. . An essential role for liver ERα in coupling hepatic metabolism to the reproductive cycle. Cell Rep. 2016;15(2):360–71. PubMed PMC

Archanco M, Muruzábal FJ, Llopiz D, Garayoa M, Gómez–Ambrosi J, Frühbeck G, et al. . Leptin expression in the rat ovary depends on estrous cycle. J Histochem Cytochem. 2003;51(10):1269–77. PubMed

Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion CNS Disord. 2001;3(1):22–7. PubMed PMC

Beyazyüz M, Albayrak Y, Eğilmez OB, Albayrak N, Beyazyüz E. Relationship between SSRIs and metabolic syndrome abnormalities in patients with generalized anxiety disorder: a prospective study. Psychiatry Investig. 2013;10(2):148–54. PubMed PMC

Rygula R, Abumaria N, Flügge G, Hiemke C, Fuchs E, Rüther E, et al. . Citalopram counteracts depressive-like symptoms evoked by chronic social stress in rats. Behav Pharmacol. 2006;17(1):19–29. PubMed

Aggarwal A, Jethani SL, Rohatgi RK, Kalra J. Selective serotonin Re-uptake inhibitors (SSRIs) induced weight changes: a dose and duration dependent study on albino rats. J Clin Diagn Res. 2016;10(3):AF01–3. PubMed PMC

Kolcsár M, Gall Z, Bíró I, László-István B, Annamaria I, Dogaru M, et al. . Fluoxetine influence on body weight, serum adiponectin level and adipose tissue triglycerides levels in rats. Farmacia. 2016;64:599–604.

Hu S, Wang L, Yang D, Li L, Togo J, Wu Y, et al. . Dietary fat, but not protein or carbohydrate, regulates energy intake and causes adiposity in mice. Cell Metab. 2018;28(3):415–31.e4. PubMed

Colotto M, Vinci F, Vo Hong N, Raimo O, Castello A, Carnovale A, et al. . Effect of treatment with selective serotonin reuptake inhibitors on lipid profile: state of the art. Clin Ter. 2012;163(1):e41–5. PubMed

Raeder MB, Bjelland I, Emil Vollset S, Steen VM. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: the hordaland health study. J Clin Psychiatry. 2006;67(12):1974–82. PubMed

da Silva AI, Braz GRF, Silva SCA, Pedroza AAS, de Lima-Júnior NC, Silva TLA, et al. . Body composition, biochemical, behavioral and molecular alterations in overfed rats after chronic exposure to SSRI. Behav Brain Res. 2019;356:62–70. PubMed

Feng XM, Xiong J, Qin H, Liu W, Chen RN, Shang W, et al. . Fluoxetine induces hepatic lipid accumulation via both promotion of the SREBP1c-related lipogenesis and reduction of lipolysis in primary mouse hepatocytes. CNS Neurosci Ther. 2012;18(12):974–80. PubMed PMC

Raeder MB, Fernø J, Glambek M, Stansberg C, Steen VM. Antidepressant drugs activate SREBP and up-regulate cholesterol and fatty acid biosynthesis in human glial cells. Neurosci Lett. 2006;395(3):185–90. PubMed

Takahashi Y, Soejima Y, Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2012;18(19):2300–8. PubMed PMC

Yu D, Chen G, Pan M, Zhang J, He W, Liu Y, et al. . High fat diet‐induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice. J Cell Physiol. 2018;233(6):4770–82. PubMed

Lu H, Lei X, Winkler R, John S, Kumar D, Li W, et al. . Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet. Lipids Health Dis. 2022;21(1):46. PubMed PMC

Habegger KM, Heppner KM, Geary N, Bartness TJ, DiMarchi R, Tschöp MH. The metabolic actions of glucagon revisited. Nat Rev Endocrinol. 2010;6(12):689–97. PubMed PMC

Yabe D, Seino Y. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. Prog Biophys Mol Biol. 2011;107(2):248–56. PubMed

Zemdegs J, Quesseveur G, Jarriault D, Pénicaud L, Fioramonti X, Guiard BP. High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice. Br J Pharmacol. 2016;173(13):2095–110. PubMed PMC

Speakman JR. Use of high-fat diets to study rodent obesity as a model of human obesity. Int J Obes. 2019;43(8):1491–2. PubMed

Takahashi M, Ikemoto S, Ezaki O. Effect of the fat/carbohydrate ratio in the diet on obesity and oral glucose tolerance in C57BL/6J mice. J Nutr Sci Vitaminol. 1999;45(5):583–93. PubMed

Nikoobakht MR, Tajik P, Karami AA, Moradi K, Mortazavi A, Kosari F. Premature ejaculation and serum leptin level: a diagnostic case-control study. J Sex Med. 2008;5(12):2942–6. PubMed

Geiser F, Conrad R, Imbierowicz K, Meier C, Liedtke R, Klingmüller D, et al. . Coagulation activation and fibrinolysis impairment are reduced in patients with anxiety and depression when medicated with serotonergic antidepressants: coagulation and serotonergic AD. Psychiatry Clin Neurosci. 2011;65(5):518–25. PubMed

Jiang H, Li X, Chen S, Lu N, Yue Y, Liang J, et al. . Plasminogen activator inhibitor-1 in depression: results from animal and clinical studies. Sci Rep. 2016;6(1):30464. PubMed PMC

Weber-Hamann B, Kratzsch J, Kopf D, Lederbogen F, Gilles M, Heuser I, et al. . Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment. J Psychiatr Res. 2007;41(3–4):344–50. PubMed

Barim AO, Aydin S, Colak R, Dag E, Deniz O, Sahin İ. Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clin Biochem. 2009;42(10–11):1076–81. PubMed